Reply to ‘Personalized treatment of immune-related adverse events — balance is required’
Crossref DOI link: https://doi.org/10.1038/s41571-020-0401-3
Published Online: 2020-06-16
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Esfahani, Kashayar http://orcid.org/0000-0003-2221-3755
Calabrese, Leonard
Text and Data Mining valid from 2020-06-16
Version of Record valid from 2020-06-16
Article History
First Online: 16 June 2020
Competing interests
: The authors declare no competing interests.
Free to read: This content has been made available to all.